Pill Version of Wegovy Is Approved for Use in the U.S, $149/mo

#1

KEY POINTS

  • The FDA has approved the first-ever GLP-1 pill from Wegovy maker Novo Nordisk.
  • Novo Nordisk said the starting dose of 1.5 milligrams will be available in early January in pharmacies and via select telehealth providers with savings offers for $149 per month.
  • The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.

F.D.A. Approves New Weight-Loss Pill - The agency greenlit an oral version of the obesity drug Wegovy. Nytimes

3 Likes
#2

Meh. Only difference with Rybelsus is bigger dose.

2 Likes
#3

Exactly. Bigger dose with more side effects and the same food restrictions. I suspect this will be a bust and quickly outclassed by orforglipron which can be taken any time of day with or without food.